Neuro-Oncology Reviews

Volume 25 Number 4
28 February 2023

Home > Publications > Neuro-Oncology Reviews > Volume 25, Year 2023 > Number 4, 28 February


Burns J, Guley N, Gokden M, Petersen E, Virmani T.
Glioblastoma, IDH-Wildtype, CNS WHO Grade 4, Associated with Deep Brain Stimulation in a Patient with Essential Tremor: Report of a Case with Molecular Characterization, and Review of the Literature.
Mov Disord Clin Pract. 2023 Feb 16;10(3):526-528. doi: 10.1002/mdc3.13672. PMID: 36949788. Case report, Review˰ ˍ

Pant A, Lim M.
CAR-T Therapy in GBM: Current Challenges and Avenues for Improvement.
Cancers (Basel). 2023 Feb 16;15(4):1249
. doi: 10.3390/cancers15041249. PMID: 36831591. Review. ˍ

Hamad A, Yusubalieva GM, Baklaushev VP, Chumakov PM, Lipatova AV.
Recent Developments in Glioblastoma Therapy: Oncolytic Viruses and Emerging Future Strategies.
Viruses. 2023 Feb 16;15(2):547
. doi: 10.3390/v15020547. PMID: 36851761. Review. ˍ

Mantica M, Drappatz J.
Immunotherapy associated central nervous system complications in primary brain tumors.
Front Oncol. 2023 Feb 16;13:1124198. doi: 10.3389/fonc.2023.1124198. PMID: 36874119. Review. ˍ

Matsuhashi A, Tanaka S, Takami H, Nomura M, Ikemura M, Matsubayashi Y, Shinoda Y, Yamada K, Sakai Y, Karasawa Y, Takayanagi S, Saito N.
Recurrent glioblastoma metastatic to the lumbar vertebra: A case report and literature review: Surgical oncology.
Front Oncol. 2023 Feb 16;13:1101552. doi: 10.3389/fonc.2023.1101552. PMID: 36874120. Case report, Review. ˍ

Stella M, Baiardi G, Pasquariello S, Sacco F, Dellacasagrande I, Corsaro A, Mattioli F, Barbieri F.
Antitumor Potential of Antiepileptic Drugs in Human Glioblastoma: Pharmacological Targets and Clinical Benefits.
Biomedicines. 2023 Feb 16;11(2):582
. doi: 10.3390/biomedicines11020582. PMID: 36831117. Review. ˍ

Chalif EJ, Foster C, Sack K, Patrick H, Mozaffari K, Rosner M.
Impact of Extent of Resection and Adjuvant Therapy in Diffuse Gliomas of the Spine.
Spine J. 2023 Feb 17:S1529-9430(23)00074-8
. doi: 10.1016/j.spinee.2023.02.010. PMID: 36804437. Observational study, Review˰ ˍ

Frederico SC, Darling C, Bielanin JP, Dubinsky AC, Zhang X, Hadjipanayis CG, Kohanbash G.
Neoadjuvant immune checkpoint inhibition in the management of glioblastoma: Exploring a new frontier.
Front Immunol. 2023 Feb 17;14:1057567. doi: 10.3389/fimmu.2023.1057567. PMID: 36875096. Review. ˍ

Ibne Mokbul M, Siddik AB.
Relationship between glioblastoma multiforme (GBM) and Alzheimer's disease (AD): is there any reporting bias?
Med Oncol. 2023 Feb 21;40(3):101
. doi: 10.1007/s12032-023-01951-9. PMID: 36809382. Editorial˰ ˍ

Tamai S, Ichinose T, Nakada M.
Liquid biomarkers in glioma.
Brain Tumor Pathol. 2023 Feb 17
. doi: 10.1007/s10014-023-00452-x. PMID: 36800124. Review˰ ˍ

Angolkar M, Paramshetti S, Halagali P, Jain V, Patil AB, Somanna P.
Nanotechnological advancements in the brain tumor therapy: a novel approach.
Ther Deliv. 2023 Feb 21
. doi: 10.4155/tde-2022-0035. PMID: 36802944. Review˰ ˍ

De Roeck L, Gillebert RC, van Aert RCM, Vanmeenen A, Klein M, Taphoorn MJB, Gehring K, Lambrecht M, Sleurs C.
Cognitive outcomes after multimodal treatment in adult glioma patients: A meta-analysis.
Neuro Oncol. 2023 Feb 21:noad045
. doi: 10.1093/neuonc/noad045. PMID: 36809489. Meta-analysis. ˍ

Fudaba H, Wakimoto H.
Oncolytic virus therapy for malignant gliomas: entering the new era.
Expert Opin Biol Ther. 2023 Feb 21
. doi: 10.1080/14712598.2023.2184256. PMID: 36809883. Review˰ ˍ

Rossi J, Cavallieri F, Bassi MC, Biagini G, Rizzi R, Russo M, Bondavalli M, Iaccarino C, Pavesi G, Cozzi S, Giaccherini L, Najafi M, Pisanello A, Valzania F.
Efficacy and Tolerability of Perampanel in Brain Tumor-Related Epilepsy: A Systematic Review.
Biomedicines. 2023 Feb 21;11(3):651. doi: 10.3390/biomedicines11030651. PMID: 36979629. Review. ˍ

Schaff LR, Mellinghoff IK.
Glioblastoma and Other Primary Brain Malignancies in Adults: A Review.
JAMA. 2023 Feb 21;329(7):574-587. doi: 10.1001/jama.2023.0023. PMID: 36809318. Review˰

Guzman G, Pellot K, Reed MR, Rodriguez A.
CAR T-cells to treat brain tumors.
Brain Res Bull. 2023 Feb 23:S0361-9230(23)00048-5
. doi: 10.1016/j.brainresbull.2023.02.014. PMID: 36841424. Review. ˍ

Luksik AS, Yazigi E, Shah P, Jackson CM.
CAR T Cell Therapy in Glioblastoma: Overcoming Challenges Related to Antigen Expression.
Cancers (Basel). 2023 Feb 23;15(5):1414. doi: 10.3390/cancers15051414. PMID: 36900205. Review. ˍ

Sharma P, Aaroe A, Liang J, Puduvalli VK.
Tumor microenvironment in glioblastoma: Current and emerging concepts.
Neurooncol Adv. 2023 Feb 23;5(1):vdad009. doi: 10.1093/noajnl/vdad009. PMID: 36968288. Review. ˍ

Barden MM, Omuro AM.
Top advances of the year: Neuro-oncology.
Cancer. 2023 Feb 24
. doi: 10.1002/cncr.34711. PMID: 36825454. Review˰ ˍ

Baqai MWS, Tariq R, Shah Z, Bajwa MH, Shamim MS.
Quality of life in survivors of pediatric medulloblastoma: a systematic review and meta-analysis.
Childs Nerv Syst. 2023 Feb 24
. doi: 10.1007/s00381-023-05886-4. PMID: 36826523. Review, Meta-analysis˰ ˍ

Schupper AJ, Hadjipanayis CG.
Novel approaches to targeting gliomas at the leading/cutting edge.
J Neurosurg. 2023 Feb 24:1-9
. doi: 10.3171/2023.1.JNS221798(?). PMID: 36840741. Review˰ ˍ

Eibl RH, Schneemann M.
Liquid biopsy and glioblastoma.
Explor Target Antitumor Ther. 2023 Feb 25;4(1):28-41. doi: 10.37349/etat.2023.00121. PMID: 36937320. Review. ˍ

Della Pepa GM, Menna G, Olivi A.
Technical Pearls to Effectively Use 5-ALA in Fluorescence-Guided Tumor Resection-5 Lessons from the Operating Room.
Brain Sci. 2023 Feb 27;13(3):411. doi: 10.3390/brainsci13030411. PMID: 36979221. Technical notes, Guidelines. ˍ

Weller M, Le Rhun E, Van den Bent M, Chang SM, Cloughesy TF, Goldbrunner R, Hong YK, Jalali R, Jenkinson MD, Minniti G, Nagane M, Razis E, Roth P, Rudà R, Tabatabai G, Wen PY, Short SC, Preusser M.
Diagnosis and management of complications from the treatment of primary central nervous system tumors in adults.
Neuro Oncol. 2023 Feb 27:noad038. doi: 10.1093/neuonc/noad038. PMID: 36843451. Review. ˍ

Kut C, Kleinberg L.
Radiotherapy, lymphopenia and improving the outcome for glioblastoma: a narrative review.
Chin Clin Oncol. 2023 Feb 28;12(1):4. doi: 10.21037/cco-22-94. PMID: 36922353. Review. ˍ

Thomas DL.
2021 updates to the World Health Organization classification of adult-type and pediatric-type diffuse gliomas: a clinical practice review.
Chin Clin Oncol. 2023 Feb 28;12(1):7. doi: 10.21037/cco-22-120. PMID: 36922356. Review. ˍ

Zhou Z, Zhu B, Meng Q, Zhang T, Wu Y, Yu R, Gao S.
Research progress in molecular pathology markers in medulloblastoma.
Explor Target Antitumor Ther. 2023 Feb 28;4(1):139-156. doi: 10.37349/etat.2023.00126. PMID: 36937322. Review. ˍ